Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Thouvenot

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
Frontiers in Immunology|May 21, 2021
Mass Cytometry Identifies Expansion of T-bet<sup>+</sup> B Cells and CD206<sup>+</sup> Monocytes in Early Multiple SclerosisLaura Couloume, Juliette Ferrant, Simon Le Gallou, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 22, 2026
Comparison of individuals with radiologically isolated syndrome, early multiple sclerosis patients, and healthy controls using a digital neurological examinationMikael Cohen, Lydiane Mondot, Xavier Ayrignac, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 19, 2025
European experience of cladribine tablets in elderly patients with multiple sclerosis: Could it be the last treatment?Jérôme de Seze, Chiara Zecca, Giovanni Castelnovo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2019
Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 StudyAlain Makinson, Jonathan Dubois, Sabrina Eymard-Duvernay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2025
Evaluation of the predictive value of CSF-restricted oligoclonal bands on residual disability and risk of relapse in adult patients with MOGAD: MOGADOC studyRyan Ramdani, Julie Pique, Romain Deschamps, et al.
Brain : a Journal of Neurology|April 21, 2022
Association between brain metabolism and clinical course of motor functional neurological disordersIsmael Conejero, Laurent Collombier, Jorge Lopez-Castroman, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 26, 2024
CD138 as a Specific CSF Biomarker of Multiple SclerosisGeoffrey Hinsinger, Lucile Du Trieu De Terdonck, Serge Urbach, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 17, 2025
Place of anti-IL6R in the therapeutic strategy in NMOSD-AQP4+, MOGAD, and NMOSD double-seronegative patientsChloé Comet, Guillaume Jouvenot, Bertrand Bourre, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2026
Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative studyMichaël Levraut, Mikael Cohen, Delphine Sterlin, et al.
Alzheimer'S Research & Therapy|October 3, 2020
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individualsSylvain Lehmann, Julien Dumurgier, Xavier Ayrignac, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|May 21, 2021
Mass Cytometry Identifies Expansion of T-bet<sup>+</sup> B Cells and CD206<sup>+</sup> Monocytes in Early Multiple SclerosisLaura Couloume, Juliette Ferrant, Simon Le Gallou, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 22, 2026
Comparison of individuals with radiologically isolated syndrome, early multiple sclerosis patients, and healthy controls using a digital neurological examinationMikael Cohen, Lydiane Mondot, Xavier Ayrignac, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 19, 2025
European experience of cladribine tablets in elderly patients with multiple sclerosis: Could it be the last treatment?Jérôme de Seze, Chiara Zecca, Giovanni Castelnovo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2019
Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 StudyAlain Makinson, Jonathan Dubois, Sabrina Eymard-Duvernay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2025
Evaluation of the predictive value of CSF-restricted oligoclonal bands on residual disability and risk of relapse in adult patients with MOGAD: MOGADOC studyRyan Ramdani, Julie Pique, Romain Deschamps, et al.
Brain : a Journal of Neurology|April 21, 2022
Association between brain metabolism and clinical course of motor functional neurological disordersIsmael Conejero, Laurent Collombier, Jorge Lopez-Castroman, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 26, 2024
CD138 as a Specific CSF Biomarker of Multiple SclerosisGeoffrey Hinsinger, Lucile Du Trieu De Terdonck, Serge Urbach, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 17, 2025
Place of anti-IL6R in the therapeutic strategy in NMOSD-AQP4+, MOGAD, and NMOSD double-seronegative patientsChloé Comet, Guillaume Jouvenot, Bertrand Bourre, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2026
Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative studyMichaël Levraut, Mikael Cohen, Delphine Sterlin, et al.
Alzheimer'S Research & Therapy|October 3, 2020
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individualsSylvain Lehmann, Julien Dumurgier, Xavier Ayrignac, et al.
Pageof 15